vs
Addus HomeCare Corp（ADUS）与科睿唯安（CLVT）财务数据对比。点击上方公司名可切换其他公司
科睿唯安的季度营收约是Addus HomeCare Corp的1.6倍（$585.5M vs $373.1M），Addus HomeCare Corp净利率更高（8.0% vs -6.9%，领先14.8%），Addus HomeCare Corp同比增速更快（25.6% vs -1.4%），科睿唯安自由现金流更多（$78.9M vs $16.1M），过去两年Addus HomeCare Corp的营收复合增速更高（15.3% vs -5.1%）
Addus HomeCare Corp是一家总部位于美国的家庭护理服务提供商，主要为老年人、残障人士及慢性病患者提供个人护理、居家健康支持、临终关怀等服务，业务覆盖美国多个州，合作方包括政府支付机构、私营保险公司及个人客户。
科睿唯安是一家英美合资的上市分析服务企业，主要提供订阅制信息服务，覆盖文献计量、科学计量、商业与市场情报领域，同时为医药、生物科技行业提供专利、监管合规相关的竞争分析，也提供商标保护、域名与品牌保护服务，旗下Web of Science产品系列还负责计算学术期刊的影响因子。
ADUS vs CLVT — 直观对比
营收规模更大
CLVT
是对方的1.6倍
$373.1M
营收增速更快
ADUS
高出26.9%
-1.4%
净利率更高
ADUS
高出14.8%
-6.9%
自由现金流更多
CLVT
多$62.8M
$16.1M
两年增速更快
ADUS
近两年复合增速
-5.1%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $373.1M | $585.5M |
| 净利润 | $29.8M | $-40.2M |
| 毛利率 | 33.1% | 67.2% |
| 营业利润率 | 11.3% | 5.2% |
| 净利率 | 8.0% | -6.9% |
| 营收同比 | 25.6% | -1.4% |
| 净利润同比 | 52.5% | 61.3% |
| 每股收益（稀释后） | $1.62 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ADUSCLVT
| Q1 26 | — | $585.5M | ||
| Q4 25 | $373.1M | $617.0M | ||
| Q3 25 | $362.3M | $623.1M | ||
| Q2 25 | $349.4M | $621.4M | ||
| Q1 25 | $337.7M | $593.7M | ||
| Q4 24 | $297.1M | $663.0M | ||
| Q3 24 | $289.8M | $622.2M | ||
| Q2 24 | $286.9M | $650.3M |
净利润ADUSCLVT
| Q1 26 | — | $-40.2M | ||
| Q4 25 | $29.8M | $3.1M | ||
| Q3 25 | $22.8M | $-28.3M | ||
| Q2 25 | $22.1M | $-72.0M | ||
| Q1 25 | $21.2M | $-103.9M | ||
| Q4 24 | $19.5M | $-191.8M | ||
| Q3 24 | $20.2M | $-65.6M | ||
| Q2 24 | $18.1M | $-304.3M |
毛利率ADUSCLVT
| Q1 26 | — | 67.2% | ||
| Q4 25 | 33.1% | 66.8% | ||
| Q3 25 | 32.2% | 65.0% | ||
| Q2 25 | 32.6% | 67.2% | ||
| Q1 25 | 31.9% | 65.1% | ||
| Q4 24 | 34.2% | 65.7% | ||
| Q3 24 | 31.8% | 66.2% | ||
| Q2 24 | 32.5% | 67.2% |
营业利润率ADUSCLVT
| Q1 26 | — | 5.2% | ||
| Q4 25 | 11.3% | 6.7% | ||
| Q3 25 | 9.1% | 7.1% | ||
| Q2 25 | 9.4% | 1.1% | ||
| Q1 25 | 9.0% | -3.5% | ||
| Q4 24 | 9.1% | -9.4% | ||
| Q3 24 | 9.0% | 3.5% | ||
| Q2 24 | 9.1% | -36.9% |
净利率ADUSCLVT
| Q1 26 | — | -6.9% | ||
| Q4 25 | 8.0% | 0.5% | ||
| Q3 25 | 6.3% | -4.5% | ||
| Q2 25 | 6.3% | -11.6% | ||
| Q1 25 | 6.3% | -17.5% | ||
| Q4 24 | 6.6% | -28.9% | ||
| Q3 24 | 7.0% | -10.5% | ||
| Q2 24 | 6.3% | -46.8% |
每股收益（稀释后）ADUSCLVT
| Q1 26 | — | $-0.06 | ||
| Q4 25 | $1.62 | $0.00 | ||
| Q3 25 | $1.24 | $-0.04 | ||
| Q2 25 | $1.20 | $-0.11 | ||
| Q1 25 | $1.16 | $-0.15 | ||
| Q4 24 | $1.06 | $-0.27 | ||
| Q3 24 | $1.10 | $-0.09 | ||
| Q2 24 | $1.10 | $-0.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | — |
| 总债务越低越好 | $121.0M | $4.3B |
| 股东权益账面价值 | $1.1B | $4.8B |
| 总资产 | $1.4B | $10.9B |
| 负债/权益比越低杠杆越低 | 0.11× | 0.89× |
8季度趋势，按日历期对齐
现金及短期投资ADUSCLVT
| Q1 26 | — | — | ||
| Q4 25 | — | $329.2M | ||
| Q3 25 | — | $318.7M | ||
| Q2 25 | — | $362.6M | ||
| Q1 25 | $97.0M | $354.0M | ||
| Q4 24 | $98.9M | $295.2M | ||
| Q3 24 | $222.9M | $388.5M | ||
| Q2 24 | $173.3M | $376.4M |
总债务ADUSCLVT
| Q1 26 | — | $4.3B | ||
| Q4 25 | $121.0M | $4.3B | ||
| Q3 25 | $150.6M | $4.4B | ||
| Q2 25 | $169.1M | $4.5B | ||
| Q1 25 | — | $4.5B | ||
| Q4 24 | $218.4M | $4.5B | ||
| Q3 24 | — | $4.6B | ||
| Q2 24 | — | $4.6B |
股东权益ADUSCLVT
| Q1 26 | — | $4.8B | ||
| Q4 25 | $1.1B | $4.8B | ||
| Q3 25 | $1.0B | $4.9B | ||
| Q2 25 | $1.0B | $5.0B | ||
| Q1 25 | $995.4M | $5.0B | ||
| Q4 24 | $970.5M | $5.1B | ||
| Q3 24 | $947.6M | $5.5B | ||
| Q2 24 | $921.7M | $5.6B |
总资产ADUSCLVT
| Q1 26 | — | $10.9B | ||
| Q4 25 | $1.4B | $11.1B | ||
| Q3 25 | $1.4B | $11.2B | ||
| Q2 25 | $1.4B | $11.4B | ||
| Q1 25 | $1.4B | $11.5B | ||
| Q4 24 | $1.4B | $11.5B | ||
| Q3 24 | $1.2B | $12.0B | ||
| Q2 24 | $1.1B | $12.1B |
负债/权益比ADUSCLVT
| Q1 26 | — | 0.89× | ||
| Q4 25 | 0.11× | 0.89× | ||
| Q3 25 | 0.14× | 0.90× | ||
| Q2 25 | 0.17× | 0.90× | ||
| Q1 25 | — | 0.90× | ||
| Q4 24 | 0.23× | 0.88× | ||
| Q3 24 | — | 0.84× | ||
| Q2 24 | — | 0.83× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $18.8M | $134.7M |
| 自由现金流经营现金流 - 资本支出 | $16.1M | $78.9M |
| 自由现金流率自由现金流/营收 | 4.3% | 13.5% |
| 资本支出强度资本支出/营收 | 0.7% | 9.5% |
| 现金转化率经营现金流/净利润 | 0.63× | — |
| 过去12个月自由现金流最近4个季度 | $103.8M | $333.9M |
8季度趋势，按日历期对齐
经营现金流ADUSCLVT
| Q1 26 | — | $134.7M | ||
| Q4 25 | $18.8M | $159.9M | ||
| Q3 25 | $51.3M | $181.1M | ||
| Q2 25 | $22.5M | $116.3M | ||
| Q1 25 | $18.9M | $171.2M | ||
| Q4 24 | $10.4M | $141.3M | ||
| Q3 24 | $48.5M | $202.9M | ||
| Q2 24 | $18.8M | $126.2M |
自由现金流ADUSCLVT
| Q1 26 | — | $78.9M | ||
| Q4 25 | $16.1M | $89.2M | ||
| Q3 25 | $49.3M | $115.5M | ||
| Q2 25 | $21.3M | $50.3M | ||
| Q1 25 | $17.1M | $110.3M | ||
| Q4 24 | $8.7M | $59.1M | ||
| Q3 24 | $46.6M | $126.3M | ||
| Q2 24 | $17.7M | $60.3M |
自由现金流率ADUSCLVT
| Q1 26 | — | 13.5% | ||
| Q4 25 | 4.3% | 14.5% | ||
| Q3 25 | 13.6% | 18.5% | ||
| Q2 25 | 6.1% | 8.1% | ||
| Q1 25 | 5.1% | 18.6% | ||
| Q4 24 | 2.9% | 8.9% | ||
| Q3 24 | 16.1% | 20.3% | ||
| Q2 24 | 6.2% | 9.3% |
资本支出强度ADUSCLVT
| Q1 26 | — | 9.5% | ||
| Q4 25 | 0.7% | 11.5% | ||
| Q3 25 | 0.5% | 10.5% | ||
| Q2 25 | 0.4% | 10.6% | ||
| Q1 25 | 0.6% | 10.3% | ||
| Q4 24 | 0.6% | 12.4% | ||
| Q3 24 | 0.7% | 12.3% | ||
| Q2 24 | 0.4% | 10.1% |
现金转化率ADUSCLVT
| Q1 26 | — | — | ||
| Q4 25 | 0.63× | 51.58× | ||
| Q3 25 | 2.24× | — | ||
| Q2 25 | 1.02× | — | ||
| Q1 25 | 0.89× | — | ||
| Q4 24 | 0.53× | — | ||
| Q3 24 | 2.41× | — | ||
| Q2 24 | 1.04× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ADUS
| Personal Care | $286.0M | 77% |
| Hospice | $70.0M | 19% |
| Home Health | $17.1M | 5% |
CLVT
| Subscription | $397.5M | 68% |
| Re-occurring | $108.6M | 19% |
| Transactional | $79.4M | 14% |
